Immunovant, Inc. (IMVT) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Price / Book | 12.46 |
| FCF Yield | -7.1% |
| Sector P/E (Healthcare) | 21.6 |
IMVT overview · IMVT earnings · IMVT KPIs · IMVT investor relations · IMVT ownership · IMVT peers · IMVT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.